| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-05 |
| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
8e-05 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-05 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |